Optimize
your health.1
Research-backed articles on peptides, TRT, longevity, nutrition, fitness, and recovery — every claim traced back to a study, not a supplement ad.
Start here
The FDA's Peptide Vote Is In: What the PCAC Actually Decided on BPC-157, TB-500, and More
The July 2026 PCAC meeting has happened — 6 of 7 peptides got a recommendation, overriding FDA's own scientists. Here's the real outcome, and why it changes less than the headlines suggest.
Parkinson's Disease: What It Is, What's FDA-Approved, and What GLP-1s, TRT, and Exercise Actually Do
GLP-1 drugs looked genuinely promising for Parkinson's in early trials — then a 667-patient meta-analysis said otherwise. Here's what the real research shows across medications, peptides, hormones, and exercise.
Retatrutide: The Next GLP-1? What We Know So Far
Retatrutide has moved from Phase 2 buzz to real Phase 3 data in the last few months. Here's what the actual trial results show, and how they stack up against tirzepatide and semaglutide.
Peptides
Research-use compounds, mechanisms, and what the data actually supports.
TRT & Hormones
Testosterone, hormone optimization, and the clinical research behind it.
Longevity
Healthspan, biomarkers, and interventions with real evidence behind them.
Fitness & Recovery
Training, recovery, and nutrition — for athletes and weekend golfers alike.
Get the Peptide Research Guide
A plain-English breakdown of the most-studied research peptides, delivered to your inbox — plus our monthly newsletter with new research and new articles. No spam, unsubscribe anytime.